Recently, TMPO-AS1 has been identified as a competitive endogenous RNA that promotes tumorigenesis of osteosarcoma by regulating the miR-199a-5p/WNT7B axis, which provides a potential therapeutic target for osteosarcoma patients (Cui and Zhao, 2019). The gene discussed is WNT7B; the disease is osteosarcoma.